NL2000291A1 - 1- (1- (2-ethoxyethyl)-3-ethyl-7- (4-methylpyridin-2-ylamino)-1H- pyrazool[4,3-d]pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan. - Google Patents

1- (1- (2-ethoxyethyl)-3-ethyl-7- (4-methylpyridin-2-ylamino)-1H- pyrazool[4,3-d]pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.

Info

Publication number: NL2000291A1
Authority: NL; Netherlands
Prior art keywords: methylpyridin; ylamino; ethoxyethyl; pyrimidin; pyrazole
Prior art date: 2005-11-10

Application number

NL2000291A

Other languages

English (en)

Other versions

NL2000291C2 (nl

Inventor

Michael Brent Tollefson

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-10

Filing date

2006-10-27

Publication date

2007-05-11

2006-10-27 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2007-05-11 Publication of NL2000291A1 publication Critical patent/NL2000291A1/nl

2009-02-17 Application granted granted Critical

2009-02-17 Publication of NL2000291C2 publication Critical patent/NL2000291C2/nl

Links

-1 2-ethoxyethyl Chemical group 0.000 title 1
SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 title 1
125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Addiction (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)

NL2000291A 2005-11-10 2006-10-27 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan. NL2000291C2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US73532005P	2005-11-10	2005-11-10
US73532005		2005-11-10

Publications (2)

Publication Number	Publication Date
NL2000291A1 true NL2000291A1 (nl)	2007-05-11
NL2000291C2 NL2000291C2 (nl)	2009-02-17

Family

ID=37685872

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL2000291A NL2000291C2 (nl)	2005-11-10	2006-10-27	1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.

Country Status (29)

Country	Link
US (2)	US20090156618A1 (nl)
EP (1)	EP1948661B1 (nl)
JP (1)	JP4208959B1 (nl)
KR (1)	KR101012592B1 (nl)
CN (1)	CN101305007B (nl)
AP (1)	AP2008004437A0 (nl)
AR (1)	AR057885A1 (nl)
AT (1)	ATE435865T1 (nl)
AU (1)	AU2006313486B2 (nl)
BR (1)	BRPI0618284A2 (nl)
CA (1)	CA2629339C (nl)
CR (1)	CR9966A (nl)
DE (1)	DE602006007728D1 (nl)
DK (1)	DK1948661T3 (nl)
DO (1)	DOP2006000248A (nl)
EA (1)	EA200800920A1 (nl)
EC (1)	ECSP088441A (nl)
ES (1)	ES2326919T3 (nl)
IL (1)	IL190456A (nl)
MA (1)	MA29943B1 (nl)
NL (1)	NL2000291C2 (nl)
NO (1)	NO20082593L (nl)
PE (1)	PE20070764A1 (nl)
RS (1)	RS20080197A (nl)
TN (1)	TNSN08209A1 (nl)
TW (1)	TW200738723A (nl)
UY (1)	UY29909A1 (nl)
WO (1)	WO2007054778A1 (nl)
ZA (1)	ZA200803173B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2011105768A (ru) *	2008-08-01	2012-09-10	Биокрист Фармасьютикалз, Инк. (Us)	Производные пиперидина в качестве ингибиторов jakз
WO2010043633A1 (en) *	2008-10-15	2010-04-22	Palau Pharma, S. A.	2h-pyrazolo [4,3-d]pyrimidin-5-amine derivatives as h4 histamine receptor antagonists for the treatment of allergic, immunological and inflammatory diseases
EP2556820A4 (en) *	2010-04-05	2015-01-21	Sk Chemicals Co Ltd	COMPOSITION CONTAINING PDE5 INHIBITOR FOR MITIGATION OF SKIN WRINKLES
EP3189835B1 (en) *	2011-02-28	2018-07-25	National Cerebral and Cardiovascular Center	Medical agent for suppressing malignant tumor metastasis
AU2012244550C1 (en)	2011-04-21	2017-06-22	Origenis Gmbh	Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
WO2014060112A1 (en)	2012-10-19	2014-04-24	Origenis Gmbh	Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
CA2888160A1 (en) *	2012-10-23	2014-05-01	Pfizer Inc.	Use of a tetrasubstituted pyrazolo[4,3-d]pyrimidine compound for treating diabetic nephropathy
MX390977B (es)	2014-08-12	2025-03-21	Mezzion Pharma Co Ltd	Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontan que utilizan composiciones de udenafilo
MX2022003593A (es)	2019-09-24	2022-09-19	Mezzion Pharma Co Ltd	Métodos para mejorar el rendimiento del ejercicio, el rendimiento ventricular único y el índice de rendimiento del miocardio (mpi) en la enfermedad cardiaca del ventrículo único, utilizando composiciones de udenafil.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0960102A1 (en)	1996-07-08	1999-12-01	Du Pont Pharmaceuticals Company	AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
ES2203078T3 (es)	1998-04-20	2004-04-01	Pfizer Inc.	Parazolopirimidinonas inhibidoras de gmpc pde5 para el tratamiento de la disfuncion sexual.
GB9822238D0 (en) *	1998-10-12	1998-12-09	Pfizer Ltd	Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
ES2205945T3 (es)	1998-10-23	2004-05-01	Pfizer Inc.	Pirazolopirimidinonas inhibidoras de gmpc pde5 para el tratamiento de disfunciones sexuales.
DE19942474A1 (de)	1999-09-06	2001-03-15	Merck Patent Gmbh	Pyrazolo[4,3-d]pyrimidine
TWI310035B (en)	2000-04-28	2009-05-21	Acadia Pharm Inc	Muscarinic agonists
DE10031584A1 (de)	2000-06-29	2002-01-10	Merck Patent Gmbh	5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
WO2002016348A1 (en)	2000-08-09	2002-02-28	Astrazeneca Ab	Antiangiogenic bicyclic derivatives
ATE478872T1 (de)	2002-03-28	2010-09-15	Ustav Ex Botan Av Cr V V I I O	Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
KR100824193B1 (ko) *	2003-04-29	2008-04-21	화이자 인코포레이티드	고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-ｄ]피리미딘
WO2004103407A2 (en)	2003-05-22	2004-12-02	Altana Pharma Ag	Composition comprising a pde4 inhibitor and a pde5 inhibitor
CA2545340A1 (en)	2003-11-10	2005-05-26	Synta Pharmaceuticals, Corp.	Fused heterocyclic compounds
GB0327319D0 (en) *	2003-11-24	2003-12-24	Pfizer Ltd	Novel pharmaceuticals
GB0327323D0 (en) *	2003-11-24	2003-12-31	Pfizer Ltd	Novel pharmaceuticals
JP2007532526A (ja) *	2004-04-07	2007-11-15	ファイザー・インク	ピラゾロ［４，３−ｄ］ピリミジン類
CA2572331A1 (en)	2004-07-02	2006-02-09	Exelixis, Inc.	C-met modulators and method of use
EP1809632A2 (en) *	2004-10-28	2007-07-25	Pharmacia & Upjohn Company LLC	Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors

2006
- 2006-10-27 NL NL2000291A patent/NL2000291C2/nl not_active IP Right Cessation
- 2006-10-31 KR KR1020087011230A patent/KR101012592B1/ko not_active Expired - Fee Related
- 2006-10-31 JP JP2008539522A patent/JP4208959B1/ja not_active Expired - Fee Related
- 2006-10-31 BR BRPI0618284-4A patent/BRPI0618284A2/pt not_active Application Discontinuation
- 2006-10-31 DK DK06809195T patent/DK1948661T3/da active
- 2006-10-31 AT AT06809195T patent/ATE435865T1/de not_active IP Right Cessation
- 2006-10-31 RS RSP-2008/0197A patent/RS20080197A/sr unknown
- 2006-10-31 CA CA2629339A patent/CA2629339C/en not_active Expired - Fee Related
- 2006-10-31 EA EA200800920A patent/EA200800920A1/ru unknown
- 2006-10-31 ES ES06809195T patent/ES2326919T3/es active Active
- 2006-10-31 WO PCT/IB2006/003132 patent/WO2007054778A1/en not_active Ceased
- 2006-10-31 DE DE602006007728T patent/DE602006007728D1/de active Active
- 2006-10-31 CN CN2006800416985A patent/CN101305007B/zh not_active Expired - Fee Related
- 2006-10-31 EP EP06809195A patent/EP1948661B1/en active Active
- 2006-10-31 AP AP2008004437A patent/AP2008004437A0/xx unknown
- 2006-10-31 AU AU2006313486A patent/AU2006313486B2/en not_active Ceased
- 2006-11-07 PE PE2006001379A patent/PE20070764A1/es not_active Application Discontinuation
- 2006-11-08 AR ARP060104894A patent/AR057885A1/es unknown
- 2006-11-09 TW TW095141515A patent/TW200738723A/zh unknown
- 2006-11-09 US US11/558,306 patent/US20090156618A1/en not_active Abandoned
- 2006-11-09 DO DO2006P000248A patent/DOP2006000248A/es unknown
- 2006-11-09 UY UY29909A patent/UY29909A1/es not_active Application Discontinuation
2008
- 2008-03-26 IL IL190456A patent/IL190456A/en not_active IP Right Cessation
- 2008-04-10 ZA ZA200803173A patent/ZA200803173B/xx unknown
- 2008-05-08 EC EC2008008441A patent/ECSP088441A/es unknown
- 2008-05-09 CR CR9966A patent/CR9966A/es not_active Application Discontinuation
- 2008-05-09 TN TNP2008000209A patent/TNSN08209A1/fr unknown
- 2008-05-09 MA MA30918A patent/MA29943B1/fr unknown
- 2008-06-10 NO NO20082593A patent/NO20082593L/no not_active Application Discontinuation
2010
- 2010-11-17 US US12/948,387 patent/US8518956B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN101305007A (zh)	2008-11-12
NO20082593L (no)	2008-07-22
KR20080063830A (ko)	2008-07-07
EP1948661A1 (en)	2008-07-30
EP1948661B1 (en)	2009-07-08
US20090156618A1 (en)	2009-06-18
AU2006313486A1 (en)	2007-05-18
KR101012592B1 (ko)	2011-02-07
TNSN08209A1 (fr)	2009-10-30
AU2006313486B2 (en)	2011-10-27
HK1120803A1 (en)	2009-04-09
US20110059993A1 (en)	2011-03-10
DE602006007728D1 (de)	2009-08-20
ATE435865T1 (de)	2009-07-15
CN101305007B (zh)	2011-07-20
DOP2006000248A (es)	2007-10-15
IL190456A0 (en)	2008-11-03
RS20080197A (sr)	2009-05-06
NL2000291C2 (nl)	2009-02-17
JP2009519215A (ja)	2009-05-14
UY29909A1 (es)	2007-06-29
CA2629339A1 (en)	2007-05-18
DK1948661T3 (da)	2009-09-07
US8518956B2 (en)	2013-08-27
TW200738723A (en)	2007-10-16
IL190456A (en)	2012-10-31
BRPI0618284A2 (pt)	2011-08-23
PE20070764A1 (es)	2007-08-13
EA200800920A1 (ru)	2008-10-30
CA2629339C (en)	2010-07-27
JP4208959B1 (ja)	2009-01-14
CR9966A (es)	2008-06-16
ES2326919T3 (es)	2009-10-21
WO2007054778A1 (en)	2007-05-18
AP2008004437A0 (en)	2008-04-30
AR057885A1 (es)	2007-12-26
MA29943B1 (fr)	2008-11-03
ZA200803173B (en)	2009-01-28
ECSP088441A (es)	2008-06-30

Legal Events

Date	Code	Title	Description
2007-07-02	AD1A	A request for search or an international type search has been filed
2008-12-01	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 20081014
2009-04-01	PD2B	A search report has been drawn up
2010-05-26	V1	Lapsed because of non-payment of the annual fee	Effective date: 20100501

Publication	Publication Date	Title
CY2024030I2 (el)	2026-02-25	Παραγωγα πυρρολο[2,3-d]πυριμιδινης ως αναστολεις πρωτεϊνικης κινασης β
AP2332A (en)	2011-12-05	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors.
NL2000323A1 (nl)	2007-06-21	Pyrimidine-derivaten.
DK2173752T4 (en)	2022-08-01	Salte af janus-kinase-inhibitor (r)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropannitril
WO2009037473A3 (en)	2009-09-11	Nucleobase characterisation
ZA200700084B (en)	2008-02-27	2,4-DI(aminopheyl) pyrimidines AS PKL inhibitors
BRPI0812563A2 (pt)	2015-02-10	Metabólitos do inibidor de janus quinase de (r)-3-(4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)-3 ciclopentilpropanonitrila
DK1824856T3 (da)	2014-01-27	2,4 (4,6)-pyrimidinderivater
IL184504A0 (en)	2007-10-31	4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors
SMAP200800029A (it)	2008-05-07	2-ammino-7,8-diidro-6h.pirido[4,3-d]pirimidin-5-oni
NL1028397A1 (nl)	2005-08-30	Werkwijze voor automatisch bepalen van het sagittale vlak.
NL2000284A1 (nl)	2007-05-07	Pyrazine-derivaten.
GB0607675D0 (en)	2006-05-31	Business Strategy Transaction Router
AP2008004687A0 (en)	2008-12-31	Insecticidal methods using 4-amino-5-chloro-thieno(2,3-d)-pyrimidine compounds
PL1879909T3 (pl)	2015-03-31	Roztwór albuminy pozbawiony cząsteczek stabilizatora
AP2008004437A0 (en)	2008-04-30	Pyrazolo Ä4,3-DÜ pyrimidin-5-yl) derivative used as PDE5 inhibitors
NL1031705A1 (nl)	2006-11-01	Aminozuurderivaten.
NL1031384A1 (nl)	2006-09-20	Gesubstitueerde aryl-1,4-pyrazinederivaten.
ITTV20050061U1 (it)	2007-06-14	Portaoggetti per mobili.
Ejouamai	2006	Modular elliptic surfaces
Ahilan	2005	Patitha Socio cultural inquerry
Milićević	2005	Milanković u delima i slici
Berglund	2005	Upplåtelseformer i nybyggda flerbostadshus
HK1116786A (en)	2009-01-02	Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors
Cox et al.	2005	Produktplacering-Ett frö till något mycket större